Loading...
Revisiting T Cell Tolerance as a Checkpoint Target for Cancer Immunotherapy
Immunotherapy has revolutionized the treatment of cancer. Nevertheless, the majority of patients do not respond to therapy, meaning a deeper understanding of tumor immune evasion strategies is required to boost treatment efficacy. The vast majority of immunotherapy studies have focused on how treatm...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7538772/ https://ncbi.nlm.nih.gov/pubmed/33072137 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.589641 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|